IMDX: Insight Molecular Diagnostics Inc. Common Stock Company Profile & Statistics

Insight Molecular Diagnostics Inc. Common Stock Profile

About

Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.

Info & Links

CEO

Joshua Riggs

Headquarters

15 CUSHING
IRVINE, CA 92618, UNITED STATES

Auditor

Marcum LLP

Share holders

182

Employees

Insight Molecular Diagnostics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

96.31M

Enterprise Value

72.02M

Enterprise Value/EBITDA(ttm)

-1.16

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

22.52

Price to Book(mrq)

87.26

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

53.27%

Operating Margin(ttm)

-505.45%

Profit Margin(ttm)

-4045.22%

Return on Equity(ttm)

-983.30%

Return on Invested Capital(ttm)

-807.44%

Return on Assets(ttm)

-39.81%

Income Statement

Revenue(ttm)

4.26M

Revenue Per Share(ttm)

0.15

Gross Profit(ttm)

2.32M

EBITDA(ttm)³

-61.83M

Net Income Available to Common(ttm)

-63.42M

Diluted EPS(ttm)

-3.47

Share Statistics

Beta (5Y Monthly)

1.24

52-Week Change

S&P 500 52-Week Change

18.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

28.62M

Dividend Yield

0.00%

Float⁴

28.03M

% Held by Insiders

2.05%

% Held by Institutions

55.35%

Balance Sheet

Total Cash(mrq)

24.29M

Total Cash Per Share(mrq)

0.85

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.04%

Quick Ratio(mrq)

3.93%

Book Value Per Share(mrq)

0.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-12.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IMDX

Insight Molecular Diagnostics Inc. Common Stock